Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Assessing independence in activities of individuals affected by leprosy

Bhat L, Khan N, Vaida N, et al. Lepra. Leprosy Review. 2022; 93 (4) : 392-407.
Download PDF
Publication

Facial nerve and branch dysfunction in leprosy - a study from India

Philip AS, George A, Mathew V, et al. Lepra. Leprosy Review. 2022; 93 (4) : 377-391.
Download PDF
Publication

Molecular detection of drug resistance in clinical specimens of leprosy patients from a tertiary care leprosy centre in South India

Muthusamy S, Vilvanathan SA, Dhandapany SP, et al. Lepra. Leprosy Review. 2022; 93 (4) : 370-376.
Download PDF
Publication

Rising percentage of new female leprosy cases since 2004

Quilter EEV, Lockwood DNJ, Ruth Butlin C. Lepra. Leprosy Review. 2022; 93 (4) : 364-369.
Download PDF
Publication

Trends and geographical variation in leprosy case detection and disability in Nepal, 2010–2021

Taal AT, Chakrawarti A, Banstola NL, et al. Lepra. Leprosy Review. 2022; 93 (4) : 348-363.
Download PDF
Publication

Health workers’ perceptions of leprosy and factors influencing their perceptions in endemic countries: A systematic literature review

Haverkort E, van ‘t Noordende AT. Lepra. Leprosy Review. 2022; 93 (4) : 332-347.
Download PDF
Publication

What factors influence adherence and non-adherence to multi-drug therapy for the treatment of leprosy within the World Health Organisation South East Asia region? A systematic review

Meadows T, Davey G. Lepra. Leprosy Review. 2022; 93 (4) : 311-331.
Download PDF
Publication

Leprosy in Europe – towards zero leprosy

Saunderson P, Fastenau A. Lepra. Leprosy Review. 2022; 93 (4) : 298-310.
Download PDF
Publication

Improving early case detection in leprosy: Reports from recent workshops

Saunderson P. Lepra. Leprosy Review. 2022; 93 (4) : 292-297.
Download PDF
Publication

Strongyloidiasis infection in a borderline lepromatous leprosy patient with adrenocorticoid insufficiency undergoing corticosteroid treatment: a case report.

Morel R, Maddumabandara K, Amarasinghe N, et al. Journal of medical case reports. 2022; 16 (1) : 458.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 215
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD